BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 194 filers reported holding BLUEBIRD BIO INC in Q3 2015. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,312,753 | -33.6% | 760,774 | -28.1% | 0.00% | -100.0% |
Q2 2023 | $3,482,821 | -31.9% | 1,058,608 | -34.2% | 0.00% | 0.0% |
Q1 2023 | $5,112,680 | -58.0% | 1,607,761 | -8.5% | 0.00% | -66.7% |
Q4 2022 | $12,165,637 | +28.4% | 1,758,040 | +17.4% | 0.00% | +50.0% |
Q3 2022 | $9,476,000 | +23.3% | 1,497,063 | -19.3% | 0.00% | 0.0% |
Q2 2022 | $7,684,000 | -24.3% | 1,855,880 | -11.4% | 0.00% | 0.0% |
Q1 2022 | $10,155,000 | -33.2% | 2,093,824 | +37.7% | 0.00% | -33.3% |
Q4 2021 | $15,192,000 | -47.1% | 1,520,751 | +1.1% | 0.00% | -50.0% |
Q3 2021 | $28,732,000 | -49.4% | 1,503,532 | -15.3% | 0.01% | -53.8% |
Q2 2021 | $56,755,000 | +84.8% | 1,774,700 | +74.2% | 0.01% | +62.5% |
Q1 2021 | $30,715,000 | -32.1% | 1,018,737 | -2.6% | 0.01% | -27.3% |
Q4 2020 | $45,238,000 | +14.4% | 1,045,485 | +42.7% | 0.01% | 0.0% |
Q3 2020 | $39,538,000 | -37.1% | 732,864 | -28.8% | 0.01% | -42.1% |
Q2 2020 | $62,866,000 | +57.6% | 1,029,909 | +18.7% | 0.02% | +35.7% |
Q1 2020 | $39,894,000 | -49.3% | 868,015 | -3.2% | 0.01% | -30.0% |
Q4 2019 | $78,664,000 | +64.0% | 896,460 | +71.6% | 0.02% | +42.9% |
Q3 2019 | $47,958,000 | -49.1% | 522,309 | -29.5% | 0.01% | -48.1% |
Q2 2019 | $94,301,000 | -8.4% | 741,363 | +13.3% | 0.03% | -12.9% |
Q1 2019 | $102,961,000 | +36.9% | 654,424 | -13.7% | 0.03% | +29.2% |
Q4 2018 | $75,204,000 | +12.2% | 758,103 | +65.2% | 0.02% | +41.2% |
Q3 2018 | $67,011,000 | -48.5% | 458,980 | -44.6% | 0.02% | -51.4% |
Q2 2018 | $130,098,000 | +15.1% | 828,916 | +25.2% | 0.04% | +20.7% |
Q1 2018 | $113,019,000 | +115.7% | 661,899 | +125.0% | 0.03% | +123.1% |
Q4 2017 | $52,385,000 | +15.9% | 294,134 | -10.6% | 0.01% | +30.0% |
Q3 2017 | $45,199,000 | -11.5% | 329,076 | -32.3% | 0.01% | -23.1% |
Q2 2017 | $51,045,000 | +48.7% | 485,912 | +28.7% | 0.01% | +30.0% |
Q1 2017 | $34,319,000 | +109.7% | 377,548 | +42.4% | 0.01% | +100.0% |
Q4 2016 | $16,364,000 | -13.6% | 265,208 | -5.1% | 0.01% | -16.7% |
Q3 2016 | $18,935,000 | +173.2% | 279,355 | +74.5% | 0.01% | +200.0% |
Q2 2016 | $6,930,000 | -61.6% | 160,086 | -62.3% | 0.00% | -66.7% |
Q1 2016 | $18,056,000 | -5.0% | 424,860 | +43.5% | 0.01% | 0.0% |
Q4 2015 | $19,012,000 | -60.7% | 296,034 | -47.7% | 0.01% | -62.5% |
Q3 2015 | $48,423,000 | -28.7% | 566,021 | +40.4% | 0.02% | -23.8% |
Q2 2015 | $67,887,000 | +105.1% | 403,206 | +47.1% | 0.02% | +90.9% |
Q1 2015 | $33,097,000 | -28.7% | 274,050 | -45.9% | 0.01% | -26.7% |
Q4 2014 | $46,434,000 | +141.4% | 506,252 | -5.6% | 0.02% | +114.3% |
Q3 2014 | $19,234,000 | +34.9% | 536,077 | +45.0% | 0.01% | +40.0% |
Q2 2014 | $14,257,000 | +1780.9% | 369,644 | +922.6% | 0.01% | – |
Q4 2013 | $758,000 | -3.7% | 36,149 | +23.9% | 0.00% | – |
Q3 2013 | $787,000 | – | 29,184 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sessa Capital IM, L.P. | 1,834,965 | $35,066,000 | 1.72% |
Birchview Capital, LP | 84,000 | $1,605,000 | 1.09% |
ARMISTICE CAPITAL, LLC | 2,472,000 | $47,240,000 | 0.80% |
EcoR1 Capital, LLC | 802,507 | $15,336,000 | 0.53% |
Parametrica Management Ltd | 36,919 | $706,000 | 0.53% |
Bain Capital Life Sciences Investors, LLC | 538,179 | $7,239,000 | 0.45% |
APPLETON GROUP, LLC | 19,495 | $373,000 | 0.32% |
MANGROVE PARTNERS IM, LLC | 175,587 | $3,355,000 | 0.30% |
Quinn Opportunity Partners LLC | 230,100 | $4,397,000 | 0.28% |
PDT Partners, LLC | 171,700 | $3,281,000 | 0.24% |